High-Value Federal Grants ($5M+) — July 03, 2026

DOE awarded $900M firm-fixed-price delivery order for domestic HALEU production over 10 years; average $90M/year provides predictable revenue and positions the small business as a key domestic supplier.

The $3.5B defense-related award is the single largest in this digest; though details are sparse, the size and defense nature of HHS contract suggest a critical mission need.

Firm-fixed-price contract for a high-containment laboratory; construction delays or cost overruns on a complex federal building project could compress margins for the joint venture.

KBR WYLE SERVICES, LLC contract with NASA Ames expires in November 2024; recompete or extension will determine if KBR retains stable ~$38.6M/year revenue stream.

MANHATTAN TORCON A JOINT VENTURE's $492M firm-fixed-price CDC lab construction: 3.9-year project with high complexity (Biosafety Level 4 containment); any cost overrun directly impacts JV margins.

AMERICAN CENTRIFUGE OPERATING's $900M firm-fixed-price HALEU production: small business must manage $90M/year execution risk; cost overruns or technology delays could erode fixed-price margins.

KBR's $365M NASA contract ends Nov 2024; recompete risk is immediate as incumbent, with full-and-open competition allowing rivals to bid.

HHS accounts for 68% of total digest value ($3.5B RAPID DEPLOYMENT + $492M MANHATTAN TORCON = $4.0B); any HHS budget cuts or CR-related delays affect majority of awards.

RAYTHEON's $607M NOAA JPSS ground system contract has only $10.2M outlaid despite $606.7M obligated; slow execution pace or potential restructuring raises questions about future outlays.

AMERICAN CENTRIFUGE OPERATING's $900M HALEU contract positions the company for long-term nuclear fuel market growth as US seeks to reduce reliance on Russian supply.

RAPID DEPLOYMENT INC's $3.5B HHS/defense contract indicates demand surge for deployable health capabilities; similar sole-source awards possible if agency deems need urgent.

CDC's $492M high-containment lab construction signals sustained biodefense infrastructure investment; follow-on contracts for similar labs (B28) at other CDC sites could reach several $B.

DOE's $900M award to AMERICAN CENTRIFUGE OPERATING for HALEU production underscores a multi-year federal push to establish independent US capacity for advanced reactor fuel.

CDC's $492M high-containment lab construction contract, combined with RAPID DEPLOYMENT INC's $3.5B defense-related HHS award, signals a broad federal commitment to biodefense readiness.

Raytheon's $607M NOAA JPSS ground system contract and KBR's $365M NASA R&D support contract demonstrate steady civilian agency spending on satellite and research operations.

{"entity"=>"AMERICAN CENTRIFUGE OPERATING, LLC", "reason"=>"Received $900M HALEU contract; small business with significant fixed-price execution risk on $90M/year revenue stream.", "trigger"=>"Fiscal year filings showing financial capacity; any DOE milestone delays"}

{"entity"=>"KBR, Inc.", "reason"=>"$365M NASA contract expiring Nov 2024; renewal announcement critical for revenue visibility.", "trigger"=>"NASA Ames re-compete solicitation or sole-source extension announcement"}

{"entity"=>"MANHATTAN TORCON A JOINT VENTURE", "reason"=>"$492M fixed-price CDC lab project; cost overruns could affect JV parent entities' margins.", "trigger"=>"Any contract modifications indicating scope changes or cost adjustments"}

{"entity"=>"RTX Corp (Raytheon)", "reason"=>"$607M NOAA contract has only $10.2M outlaid; slow execution or restructuring risk.", "trigger"=>"NOAA outlay reports or contract modification announcements"}

{"entity"=>"HHS budget trajectory", "reason"=>"68% of digest value tied to HHS ($4.0B); CR risk and FY2027 appropriations critical.", "trigger"=>"FY2027 HHS budget request; Continuing Resolution status post-Oct 2026"}